Adage Capital Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,200,000
| Closed | -$21.3M | – | 786 |
|
|
2018
Q3 | $21.3M | Buy |
1,200,000
+450,000
| +60% | +$7.99M | 0.05% | 384 |
|
|
2018
Q2 | $10.4M | Sell |
750,000
-750,000
| -50% | -$10.4M | 0.02% | 560 |
|
|
2018
Q1 | $13.6M | Buy |
1,500,000
+1,378,000
| +1,130% | +$12.5M | 0.03% | 494 |
|
|
2017
Q4 | $522K | Buy |
+122,000
| New | +$522K | ﹤0.01% | 688 |
|
|
2014
Q2 | – | Sell |
-619,559
| Closed | -$14.8M | – | 769 |
|
|
2014
Q1 | $14.8M | Buy |
+619,559
| New | +$14.8M | 0.04% | 432 |
|